Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenue, net $ 3,612 $ 2,253 $ 6,647 $ 4,370
Cost of revenue (excluding amortization of $970 and $986 for the three months and $1,939 and $1,839 for the six months, respectively) 1,842 1,851 3,020 3,425
Gross profit 1,770 402 3,627 945
Operating expenses:        
Sales and marketing 1,322 3,285 2,904 5,511
Research and development 357 414 680 646
General and administrative 2,015 3,430 4,797 6,411
Acquisition related amortization expense 970 986 1,939 1,839
Total operating expenses 4,664 8,115 10,320 14,407
Operating loss (2,894) (7,713) (6,693) (13,462)
Interest expense (858) (884) (1,062) (1,732)
Other income (expense), net 3 (69) 10 (155)
Loss from continuing operations before tax (3,749) (8,666) (7,745) (15,349)
Benefit from income taxes (236) (177) (227) (250)
Loss from continuing operations (3,513) (8,489) (7,518) (15,099)
Income from discontinued operations, net of tax 1,179 1,511 398 4,253
Net loss (2,334) (6,978) (7,120) (10,846)
Net Loss and Comprehensive Loss $ (2,334) $ (6,978) $ (7,120) $ (10,846)
Basic and diluted loss per share of common stock:        
From continuing operations (in dollars per share) $ (0.19) $ (0.56) $ (0.42) $ (1)
From discontinued operations (in dollars per share) 0.06 0.10 0.02 0.28
Net loss per basic and diluted share of common stock (in dollars per share) $ (0.13) $ (0.46) $ (0.40) $ (0.72)
Weighted average number of common shares and common share equivalents outstanding:        
Basic weighted average number of of common shares (in shares) 18,163 15,204 17,962 15,121
Diluted (in shares) 18,163 15,204 17,962 15,121